| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Memory | 40 | 2020 | 174 | 6.950 |
Why?
|
| Dendritic Spines | 21 | 2023 | 35 | 6.900 |
Why?
|
| Estradiol | 52 | 2020 | 268 | 6.150 |
Why?
|
| Biogenic Monoamines | 17 | 2010 | 32 | 2.700 |
Why?
|
| Estrogens | 20 | 2022 | 203 | 2.690 |
Why?
|
| Hippocampus | 37 | 2022 | 594 | 2.670 |
Why?
|
| Cognition | 16 | 2023 | 473 | 2.410 |
Why?
|
| Prefrontal Cortex | 17 | 2022 | 164 | 2.140 |
Why?
|
| Sex Characteristics | 15 | 2022 | 258 | 2.070 |
Why?
|
| Stress, Physiological | 13 | 2015 | 172 | 1.910 |
Why?
|
| Rats | 102 | 2022 | 3735 | 1.800 |
Why?
|
| Stress, Psychological | 10 | 2016 | 661 | 1.770 |
Why?
|
| Phenols | 8 | 2020 | 107 | 1.750 |
Why?
|
| Rats, Sprague-Dawley | 42 | 2022 | 1766 | 1.620 |
Why?
|
| Animals | 142 | 2023 | 16992 | 1.610 |
Why?
|
| Space Perception | 15 | 2008 | 35 | 1.470 |
Why?
|
| Brain | 39 | 2012 | 1472 | 1.390 |
Why?
|
| CA1 Region, Hippocampal | 4 | 2017 | 35 | 1.390 |
Why?
|
| Serotonin | 29 | 2008 | 123 | 1.360 |
Why?
|
| Memory Disorders | 9 | 2021 | 77 | 1.270 |
Why?
|
| Maze Learning | 19 | 2021 | 113 | 1.250 |
Why?
|
| Androgens | 6 | 2022 | 106 | 1.240 |
Why?
|
| Gonadal Steroid Hormones | 10 | 2012 | 55 | 1.180 |
Why?
|
| Sexual Behavior, Animal | 21 | 1999 | 64 | 1.020 |
Why?
|
| Ovariectomy | 19 | 2022 | 127 | 0.960 |
Why?
|
| Female | 99 | 2023 | 24698 | 0.930 |
Why?
|
| Endocrine Disruptors | 3 | 2022 | 44 | 0.930 |
Why?
|
| Aging | 13 | 2015 | 783 | 0.910 |
Why?
|
| Benzhydryl Compounds | 6 | 2020 | 50 | 0.910 |
Why?
|
| Rodentia | 4 | 2020 | 47 | 0.910 |
Why?
|
| Hypothalamus | 26 | 1997 | 120 | 0.850 |
Why?
|
| Receptors, Estrogen | 10 | 2012 | 183 | 0.840 |
Why?
|
| Anxiety | 7 | 2014 | 874 | 0.840 |
Why?
|
| Learning | 7 | 2020 | 161 | 0.810 |
Why?
|
| Estrogens, Non-Steroidal | 3 | 2012 | 20 | 0.790 |
Why?
|
| Restraint, Physical | 9 | 2013 | 22 | 0.790 |
Why?
|
| Steroids | 1 | 2023 | 45 | 0.760 |
Why?
|
| Brain-Derived Neurotrophic Factor | 4 | 2012 | 81 | 0.730 |
Why?
|
| Brain Chemistry | 13 | 2010 | 141 | 0.680 |
Why?
|
| Neurons | 11 | 2011 | 1263 | 0.650 |
Why?
|
| Male | 65 | 2023 | 23409 | 0.650 |
Why?
|
| Spatial Behavior | 5 | 2010 | 22 | 0.620 |
Why?
|
| Memory, Short-Term | 5 | 2021 | 59 | 0.590 |
Why?
|
| Pyramidal Cells | 5 | 2014 | 65 | 0.580 |
Why?
|
| Behavior, Animal | 11 | 2021 | 373 | 0.580 |
Why?
|
| Testosterone | 17 | 2022 | 211 | 0.570 |
Why?
|
| Corticosterone | 13 | 2014 | 90 | 0.570 |
Why?
|
| Prenatal Exposure Delayed Effects | 4 | 2011 | 192 | 0.570 |
Why?
|
| Neuronal Plasticity | 6 | 2015 | 126 | 0.560 |
Why?
|
| Pseudopodia | 1 | 2017 | 17 | 0.540 |
Why?
|
| Receptors, AMPA | 1 | 2017 | 58 | 0.530 |
Why?
|
| Choline O-Acetyltransferase | 15 | 1993 | 36 | 0.510 |
Why?
|
| Progesterone | 16 | 2010 | 121 | 0.480 |
Why?
|
| Motor Activity | 7 | 2010 | 437 | 0.480 |
Why?
|
| Gonadal Hormones | 1 | 2016 | 5 | 0.480 |
Why?
|
| Norepinephrine | 17 | 2010 | 97 | 0.470 |
Why?
|
| Neuropsychological Tests | 3 | 2014 | 284 | 0.470 |
Why?
|
| Adrenal Cortex Hormones | 3 | 2014 | 64 | 0.470 |
Why?
|
| Hormones | 6 | 2023 | 55 | 0.460 |
Why?
|
| Time Factors | 18 | 2016 | 1857 | 0.460 |
Why?
|
| Estrogen Receptor beta | 3 | 2010 | 39 | 0.460 |
Why?
|
| Pregnancy | 8 | 2011 | 1772 | 0.430 |
Why?
|
| Cocaine | 4 | 2011 | 251 | 0.430 |
Why?
|
| Posture | 14 | 1999 | 61 | 0.420 |
Why?
|
| Dopamine | 11 | 2006 | 275 | 0.410 |
Why?
|
| Neurotransmitter Agents | 7 | 2008 | 69 | 0.410 |
Why?
|
| Alcohols | 1 | 2013 | 14 | 0.410 |
Why?
|
| Ethanol | 2 | 2013 | 224 | 0.400 |
Why?
|
| Postpartum Period | 2 | 2011 | 92 | 0.400 |
Why?
|
| Pyrazoles | 2 | 2010 | 103 | 0.390 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2013 | 23 | 0.390 |
Why?
|
| Cognition Disorders | 5 | 2014 | 243 | 0.390 |
Why?
|
| Exploratory Behavior | 6 | 2013 | 78 | 0.380 |
Why?
|
| Central Nervous System Depressants | 1 | 2013 | 42 | 0.380 |
Why?
|
| Discrimination Learning | 3 | 2010 | 38 | 0.380 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2012 | 66 | 0.370 |
Why?
|
| gamma-Aminobutyric Acid | 4 | 2004 | 81 | 0.370 |
Why?
|
| Parity | 2 | 2009 | 59 | 0.340 |
Why?
|
| Cerebral Cortex | 7 | 2010 | 306 | 0.340 |
Why?
|
| Central Nervous System | 2 | 2012 | 152 | 0.340 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2011 | 83 | 0.330 |
Why?
|
| Fluorenes | 1 | 2010 | 26 | 0.330 |
Why?
|
| Sex Differentiation | 2 | 2009 | 13 | 0.320 |
Why?
|
| Methamphetamine | 2 | 2021 | 166 | 0.310 |
Why?
|
| Rats, Inbred F344 | 10 | 2010 | 258 | 0.310 |
Why?
|
| Hydroxyindoleacetic Acid | 12 | 2010 | 12 | 0.300 |
Why?
|
| Depression | 2 | 2013 | 863 | 0.300 |
Why?
|
| Reproduction | 1 | 2009 | 94 | 0.290 |
Why?
|
| Body Weight | 5 | 2013 | 429 | 0.290 |
Why?
|
| Preoptic Area | 11 | 2008 | 15 | 0.270 |
Why?
|
| Pattern Recognition, Physiological | 1 | 2007 | 2 | 0.270 |
Why?
|
| Neurotransmitter Transport Proteins | 1 | 2007 | 3 | 0.270 |
Why?
|
| Nitriles | 2 | 2022 | 81 | 0.260 |
Why?
|
| Thiazepines | 3 | 1995 | 4 | 0.260 |
Why?
|
| Antidepressive Agents, Tricyclic | 3 | 1995 | 15 | 0.260 |
Why?
|
| Analysis of Variance | 5 | 2013 | 575 | 0.260 |
Why?
|
| 5,7-Dihydroxytryptamine | 7 | 1992 | 7 | 0.250 |
Why?
|
| Catecholamines | 5 | 1998 | 45 | 0.250 |
Why?
|
| Orchiectomy | 2 | 2017 | 37 | 0.250 |
Why?
|
| Alcohol Drinking | 1 | 2012 | 609 | 0.250 |
Why?
|
| Phytoestrogens | 1 | 2006 | 39 | 0.250 |
Why?
|
| Pargyline | 7 | 1995 | 11 | 0.240 |
Why?
|
| Biogenic Amines | 4 | 1986 | 13 | 0.230 |
Why?
|
| Estrogen Replacement Therapy | 4 | 2014 | 42 | 0.230 |
Why?
|
| Fluoxetine | 2 | 1995 | 15 | 0.230 |
Why?
|
| Disease Models, Animal | 7 | 2013 | 1596 | 0.230 |
Why?
|
| Sex Factors | 8 | 2021 | 1028 | 0.220 |
Why?
|
| Chronic Disease | 5 | 2007 | 549 | 0.220 |
Why?
|
| Synaptophysin | 1 | 2004 | 6 | 0.220 |
Why?
|
| Amphetamine | 1 | 2004 | 21 | 0.220 |
Why?
|
| Amygdala | 9 | 2009 | 125 | 0.210 |
Why?
|
| Neurosecretory Systems | 2 | 2010 | 17 | 0.210 |
Why?
|
| Humans | 29 | 2020 | 43102 | 0.210 |
Why?
|
| Behavior | 3 | 2020 | 35 | 0.210 |
Why?
|
| Androstenedione | 2 | 2022 | 19 | 0.200 |
Why?
|
| Dihydrotestosterone | 2 | 2022 | 28 | 0.200 |
Why?
|
| Proline | 2 | 2002 | 40 | 0.200 |
Why?
|
| Dextroamphetamine | 1 | 2003 | 9 | 0.200 |
Why?
|
| Central Nervous System Stimulants | 2 | 2021 | 180 | 0.200 |
Why?
|
| Dihydroxytryptamines | 4 | 1987 | 4 | 0.190 |
Why?
|
| Indans | 1 | 2002 | 14 | 0.190 |
Why?
|
| Benzopyrans | 1 | 2002 | 25 | 0.190 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2002 | 44 | 0.190 |
Why?
|
| Dehydroepiandrosterone | 1 | 2022 | 10 | 0.190 |
Why?
|
| Food Deprivation | 3 | 1999 | 33 | 0.190 |
Why?
|
| Piperidines | 1 | 2002 | 83 | 0.190 |
Why?
|
| Aromatase Inhibitors | 1 | 2022 | 19 | 0.190 |
Why?
|
| Sexual Maturation | 2 | 2020 | 24 | 0.190 |
Why?
|
| Rats, Inbred Strains | 18 | 1991 | 126 | 0.180 |
Why?
|
| Nicotinic Agonists | 1 | 2002 | 88 | 0.180 |
Why?
|
| Monoamine Oxidase | 7 | 1986 | 37 | 0.180 |
Why?
|
| Triazoles | 1 | 2022 | 102 | 0.170 |
Why?
|
| Corpus Striatum | 1 | 2002 | 121 | 0.170 |
Why?
|
| Proestrus | 2 | 2007 | 2 | 0.170 |
Why?
|
| Synapses | 5 | 2006 | 185 | 0.170 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2021 | 69 | 0.170 |
Why?
|
| Genomics | 1 | 2023 | 293 | 0.160 |
Why?
|
| Castration | 16 | 1986 | 34 | 0.160 |
Why?
|
| Neuroendocrinology | 1 | 2020 | 2 | 0.160 |
Why?
|
| Neuroprotective Agents | 1 | 2003 | 269 | 0.160 |
Why?
|
| Neural Pathways | 4 | 2008 | 138 | 0.160 |
Why?
|
| Golgi Apparatus | 2 | 2012 | 27 | 0.160 |
Why?
|
| History, 21st Century | 1 | 2020 | 83 | 0.160 |
Why?
|
| History, 20th Century | 1 | 2020 | 121 | 0.150 |
Why?
|
| Form Perception | 1 | 1999 | 5 | 0.150 |
Why?
|
| Animals, Newborn | 4 | 2011 | 352 | 0.150 |
Why?
|
| Amino Acids | 1 | 1999 | 148 | 0.140 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 3 | 2010 | 27 | 0.140 |
Why?
|
| Mental Recall | 2 | 1997 | 84 | 0.140 |
Why?
|
| Radioimmunoassay | 3 | 2012 | 70 | 0.140 |
Why?
|
| Pituitary Gland | 9 | 1986 | 60 | 0.130 |
Why?
|
| Acetylcholinesterase | 8 | 1984 | 56 | 0.130 |
Why?
|
| Administration, Oral | 3 | 2021 | 260 | 0.120 |
Why?
|
| Estrogen Receptor alpha | 2 | 2010 | 121 | 0.120 |
Why?
|
| Postmenopause | 1 | 1997 | 141 | 0.120 |
Why?
|
| Psychomotor Performance | 2 | 2013 | 159 | 0.120 |
Why?
|
| Glutamic Acid | 1 | 1997 | 131 | 0.120 |
Why?
|
| Acetylcholine | 2 | 1993 | 77 | 0.110 |
Why?
|
| Receptors, Cholinergic | 4 | 1984 | 28 | 0.110 |
Why?
|
| Menopause | 1 | 2014 | 64 | 0.110 |
Why?
|
| Imipramine | 2 | 1985 | 9 | 0.110 |
Why?
|
| Anxiety Disorders | 2 | 2008 | 322 | 0.110 |
Why?
|
| MAP Kinase Signaling System | 1 | 2016 | 196 | 0.100 |
Why?
|
| Silver Staining | 2 | 2011 | 7 | 0.100 |
Why?
|
| Chromatography, High Pressure Liquid | 5 | 2002 | 465 | 0.100 |
Why?
|
| Swimming | 1 | 2013 | 41 | 0.100 |
Why?
|
| Longevity | 1 | 2015 | 173 | 0.100 |
Why?
|
| Methoxyhydroxyphenylglycol | 2 | 2010 | 17 | 0.100 |
Why?
|
| Receptors, GABA | 1 | 2013 | 28 | 0.100 |
Why?
|
| Uterus | 3 | 2006 | 52 | 0.100 |
Why?
|
| Prosencephalon | 1 | 1993 | 37 | 0.100 |
Why?
|
| Environmental Exposure | 1 | 2014 | 256 | 0.090 |
Why?
|
| Adrenalectomy | 7 | 1994 | 23 | 0.090 |
Why?
|
| Age Factors | 5 | 2014 | 1154 | 0.090 |
Why?
|
| Visual Perception | 3 | 2014 | 80 | 0.090 |
Why?
|
| Ovary | 8 | 1977 | 113 | 0.090 |
Why?
|
| Baclofen | 1 | 1991 | 9 | 0.090 |
Why?
|
| Choice Behavior | 1 | 2012 | 93 | 0.090 |
Why?
|
| Frontal Lobe | 4 | 1994 | 58 | 0.090 |
Why?
|
| Stimulation, Chemical | 2 | 2002 | 20 | 0.090 |
Why?
|
| Weight Gain | 2 | 2004 | 139 | 0.080 |
Why?
|
| Fenfluramine | 1 | 2010 | 2 | 0.080 |
Why?
|
| Propionates | 1 | 2010 | 27 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2013 | 883 | 0.080 |
Why?
|
| Neostriatum | 1 | 2010 | 28 | 0.080 |
Why?
|
| Dendrites | 2 | 2004 | 57 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 113 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2011 | 200 | 0.080 |
Why?
|
| Cell Nucleus | 7 | 1986 | 383 | 0.080 |
Why?
|
| Monoamine Oxidase Inhibitors | 2 | 1995 | 28 | 0.070 |
Why?
|
| Dynorphins | 1 | 2008 | 17 | 0.070 |
Why?
|
| Glucosephosphate Dehydrogenase | 8 | 1986 | 15 | 0.070 |
Why?
|
| Maternal Behavior | 1 | 2008 | 29 | 0.070 |
Why?
|
| Receptors, Progesterone | 3 | 1987 | 92 | 0.070 |
Why?
|
| Organ Size | 2 | 2006 | 170 | 0.070 |
Why?
|
| Muscles | 3 | 1984 | 82 | 0.070 |
Why?
|
| Drug Administration Schedule | 2 | 2002 | 153 | 0.070 |
Why?
|
| Synaptic Transmission | 2 | 2007 | 149 | 0.070 |
Why?
|
| Septum of Brain | 1 | 2007 | 1 | 0.070 |
Why?
|
| Ovulation | 1 | 2007 | 21 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2011 | 561 | 0.070 |
Why?
|
| Receptors, Cell Surface | 3 | 1978 | 146 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2007 | 1124 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 4 | 2021 | 1869 | 0.070 |
Why?
|
| Trachea | 2 | 1984 | 25 | 0.060 |
Why?
|
| Mothers | 1 | 2009 | 215 | 0.060 |
Why?
|
| Cocaine-Related Disorders | 1 | 2007 | 102 | 0.060 |
Why?
|
| Food, Formulated | 1 | 2006 | 4 | 0.060 |
Why?
|
| Cortisone | 1 | 2006 | 3 | 0.060 |
Why?
|
| Problem Solving | 1 | 2006 | 38 | 0.060 |
Why?
|
| Cholinergic Fibers | 3 | 1993 | 12 | 0.060 |
Why?
|
| Association Learning | 1 | 2006 | 35 | 0.060 |
Why?
|
| Diencephalon | 1 | 1986 | 7 | 0.060 |
Why?
|
| Estrous Cycle | 2 | 2008 | 37 | 0.060 |
Why?
|
| Telencephalon | 1 | 1986 | 13 | 0.060 |
Why?
|
| Adaptation, Physiological | 1 | 2007 | 143 | 0.060 |
Why?
|
| Limbic System | 2 | 1985 | 31 | 0.060 |
Why?
|
| Vocalization, Animal | 3 | 1984 | 55 | 0.060 |
Why?
|
| Action Potentials | 1 | 2007 | 246 | 0.060 |
Why?
|
| Alzheimer Disease | 5 | 1997 | 1001 | 0.060 |
Why?
|
| Homovanillic Acid | 2 | 2002 | 10 | 0.060 |
Why?
|
| Reference Values | 3 | 1994 | 211 | 0.060 |
Why?
|
| Raphe Nuclei | 1 | 1984 | 6 | 0.060 |
Why?
|
| Naloxone | 1 | 1985 | 56 | 0.060 |
Why?
|
| Naltrexone | 1 | 1985 | 34 | 0.060 |
Why?
|
| Neuromuscular Junction | 2 | 1982 | 35 | 0.060 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 1993 | 92 | 0.050 |
Why?
|
| Vitamin D | 1 | 1987 | 196 | 0.050 |
Why?
|
| Cerebrospinal Fluid | 1 | 2004 | 20 | 0.050 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 1984 | 10 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2006 | 536 | 0.050 |
Why?
|
| Testis | 2 | 1975 | 207 | 0.050 |
Why?
|
| Periaqueductal Gray | 2 | 1993 | 11 | 0.050 |
Why?
|
| Diethylstilbestrol | 1 | 2003 | 11 | 0.050 |
Why?
|
| Ventromedial Hypothalamic Nucleus | 2 | 1993 | 6 | 0.050 |
Why?
|
| Pyramidal Tracts | 2 | 1994 | 35 | 0.050 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2003 | 31 | 0.050 |
Why?
|
| Sexual Behavior | 1 | 2008 | 638 | 0.050 |
Why?
|
| Mice | 5 | 2021 | 6644 | 0.050 |
Why?
|
| Housing, Animal | 1 | 2002 | 12 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2006 | 1604 | 0.050 |
Why?
|
| Birds | 4 | 1984 | 96 | 0.040 |
Why?
|
| Nitromifene | 2 | 1982 | 2 | 0.040 |
Why?
|
| Receptors, Opioid, kappa | 1 | 2021 | 23 | 0.040 |
Why?
|
| Reaction Time | 1 | 2002 | 157 | 0.040 |
Why?
|
| Pyrrolidines | 2 | 1982 | 31 | 0.040 |
Why?
|
| Hydrocortisone | 2 | 1999 | 93 | 0.040 |
Why?
|
| Receptors, Steroid | 4 | 1984 | 38 | 0.040 |
Why?
|
| Receptors, Glucocorticoid | 3 | 1994 | 35 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 2021 | 124 | 0.040 |
Why?
|
| Laryngeal Nerves | 1 | 1980 | 9 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 3 | 2004 | 386 | 0.040 |
Why?
|
| Endorphins | 2 | 1993 | 4 | 0.040 |
Why?
|
| Anisomycin | 3 | 1985 | 8 | 0.040 |
Why?
|
| Motor Neurons | 1 | 1980 | 90 | 0.040 |
Why?
|
| Luteinizing Hormone | 4 | 1987 | 61 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2004 | 1271 | 0.040 |
Why?
|
| Bicuculline | 1 | 1999 | 18 | 0.040 |
Why?
|
| GABA Antagonists | 1 | 1999 | 29 | 0.040 |
Why?
|
| Proline Oxidase | 1 | 1999 | 11 | 0.040 |
Why?
|
| Tissue Distribution | 2 | 1993 | 240 | 0.040 |
Why?
|
| Catechol O-Methyltransferase | 1 | 1998 | 18 | 0.040 |
Why?
|
| Mossy Fibers, Hippocampal | 2 | 2008 | 10 | 0.040 |
Why?
|
| Protein Biosynthesis | 2 | 1978 | 132 | 0.030 |
Why?
|
| Hypothalamus, Middle | 1 | 1977 | 4 | 0.030 |
Why?
|
| Autoantibodies | 2 | 1988 | 117 | 0.030 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1995 | 104 | 0.030 |
Why?
|
| Mesencephalon | 2 | 1991 | 49 | 0.030 |
Why?
|
| Acetyltransferases | 1 | 1975 | 27 | 0.030 |
Why?
|
| Orientation | 1 | 1994 | 33 | 0.030 |
Why?
|
| Cell Count | 1 | 2014 | 145 | 0.030 |
Why?
|
| Phenytoin | 1 | 1994 | 2 | 0.030 |
Why?
|
| Aldosterone | 1 | 1994 | 66 | 0.030 |
Why?
|
| Receptors, Opioid, delta | 1 | 1993 | 23 | 0.030 |
Why?
|
| Median Eminence | 1 | 1993 | 10 | 0.030 |
Why?
|
| Injections | 1 | 1993 | 42 | 0.030 |
Why?
|
| Myelin Sheath | 2 | 2010 | 46 | 0.020 |
Why?
|
| Receptors, Opioid, mu | 1 | 1993 | 52 | 0.020 |
Why?
|
| Dopamine beta-Hydroxylase | 1 | 1993 | 9 | 0.020 |
Why?
|
| Microfilament Proteins | 2 | 2004 | 72 | 0.020 |
Why?
|
| NADP | 2 | 1979 | 37 | 0.020 |
Why?
|
| Afferent Pathways | 1 | 1993 | 43 | 0.020 |
Why?
|
| Cytosol | 4 | 1987 | 97 | 0.020 |
Why?
|
| 8-Hydroxy-2-(di-n-propylamino)tetralin | 1 | 1992 | 7 | 0.020 |
Why?
|
| Mammals | 1 | 1993 | 112 | 0.020 |
Why?
|
| Brain Mapping | 1 | 1993 | 137 | 0.020 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1991 | 27 | 0.020 |
Why?
|
| Piperazines | 1 | 1992 | 120 | 0.020 |
Why?
|
| Kinetics | 4 | 1989 | 695 | 0.020 |
Why?
|
| Enzyme Activation | 2 | 1984 | 462 | 0.020 |
Why?
|
| Arousal | 1 | 1991 | 95 | 0.020 |
Why?
|
| Electrochemistry | 1 | 1990 | 38 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2004 | 934 | 0.020 |
Why?
|
| Spinal Cord | 1 | 1971 | 114 | 0.020 |
Why?
|
| Vasopressins | 1 | 1990 | 12 | 0.020 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2010 | 23 | 0.020 |
Why?
|
| Aged | 5 | 1997 | 8214 | 0.020 |
Why?
|
| Sesame Oil | 1 | 2010 | 2 | 0.020 |
Why?
|
| Phosphogluconate Dehydrogenase | 3 | 1975 | 3 | 0.020 |
Why?
|
| Isocitrate Dehydrogenase | 3 | 1975 | 13 | 0.020 |
Why?
|
| Epinephrine | 1 | 1989 | 36 | 0.020 |
Why?
|
| Malate Dehydrogenase | 3 | 1975 | 8 | 0.020 |
Why?
|
| Neurochemistry | 2 | 2004 | 6 | 0.020 |
Why?
|
| Prolactin | 2 | 2004 | 65 | 0.020 |
Why?
|
| Lipids | 1 | 1971 | 256 | 0.020 |
Why?
|
| Antibodies | 1 | 1989 | 144 | 0.020 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2008 | 35 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1999 | 267 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2010 | 259 | 0.020 |
Why?
|
| Diestrus | 1 | 2007 | 1 | 0.020 |
Why?
|
| Time | 1 | 2007 | 15 | 0.020 |
Why?
|
| Menstrual Cycle | 1 | 2007 | 36 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2007 | 101 | 0.020 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2007 | 80 | 0.020 |
Why?
|
| Pituitary-Adrenal System | 1 | 1987 | 41 | 0.020 |
Why?
|
| Comorbidity | 1 | 2010 | 737 | 0.020 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 1987 | 17 | 0.020 |
Why?
|
| Recurrence | 1 | 2007 | 152 | 0.020 |
Why?
|
| Glycosaminoglycans | 1 | 1987 | 24 | 0.020 |
Why?
|
| Muscle Denervation | 2 | 1984 | 4 | 0.020 |
Why?
|
| Glycerolphosphate Dehydrogenase | 2 | 1984 | 4 | 0.020 |
Why?
|
| Proteoglycans | 1 | 1987 | 49 | 0.020 |
Why?
|
| Proteins | 2 | 1982 | 382 | 0.020 |
Why?
|
| Androstatrienes | 1 | 1986 | 1 | 0.020 |
Why?
|
| Reward | 1 | 2007 | 112 | 0.020 |
Why?
|
| Middle Aged | 4 | 1997 | 12222 | 0.020 |
Why?
|
| Calcitriol | 1 | 1986 | 32 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 1999 | 1180 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 1999 | 1542 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 1987 | 259 | 0.010 |
Why?
|
| Injections, Intraventricular | 1 | 1985 | 59 | 0.010 |
Why?
|
| Estrogens, Catechol | 2 | 1982 | 2 | 0.010 |
Why?
|
| Hexokinase | 2 | 1975 | 10 | 0.010 |
Why?
|
| Denervation | 1 | 1984 | 27 | 0.010 |
Why?
|
| Spinal Puncture | 1 | 2004 | 2 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 1975 | 64 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1985 | 150 | 0.010 |
Why?
|
| Ganglia, Sympathetic | 1 | 1984 | 3 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2006 | 456 | 0.010 |
Why?
|
| Fetus | 1 | 1984 | 101 | 0.010 |
Why?
|
| Oxytocin | 1 | 2004 | 24 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2004 | 210 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2004 | 139 | 0.010 |
Why?
|
| Androsterone | 1 | 1983 | 2 | 0.010 |
Why?
|
| Peripheral Nerves | 1 | 1983 | 14 | 0.010 |
Why?
|
| Presynaptic Terminals | 1 | 2004 | 54 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 1984 | 127 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2008 | 1070 | 0.010 |
Why?
|
| Tritium | 1 | 1983 | 46 | 0.010 |
Why?
|
| Binding Sites | 1 | 1985 | 671 | 0.010 |
Why?
|
| Radioimmunodetection | 1 | 2002 | 1 | 0.010 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2002 | 3 | 0.010 |
Why?
|
| Isoenzymes | 1 | 1983 | 168 | 0.010 |
Why?
|
| Histological Techniques | 1 | 2002 | 12 | 0.010 |
Why?
|
| Clorgyline | 1 | 1982 | 4 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2004 | 694 | 0.010 |
Why?
|
| Progestins | 1 | 1982 | 11 | 0.010 |
Why?
|
| Choline | 2 | 1988 | 61 | 0.010 |
Why?
|
| Risk Factors | 1 | 2010 | 3994 | 0.010 |
Why?
|
| Hydroxyestrones | 1 | 1981 | 8 | 0.010 |
Why?
|
| Estrone | 1 | 1981 | 21 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 2000 | 36 | 0.010 |
Why?
|
| Receptors, Muscarinic | 1 | 1980 | 16 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2000 | 60 | 0.010 |
Why?
|
| Laryngeal Muscles | 1 | 1980 | 6 | 0.010 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 1999 | 4 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 1999 | 83 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1999 | 150 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 1999 | 42 | 0.010 |
Why?
|
| Acoustic Stimulation | 1 | 1999 | 78 | 0.010 |
Why?
|
| Cell Fractionation | 2 | 1977 | 29 | 0.010 |
Why?
|
| Insect Proteins | 1 | 1999 | 53 | 0.010 |
Why?
|
| RNA | 2 | 1978 | 266 | 0.010 |
Why?
|
| Homozygote | 1 | 1998 | 77 | 0.010 |
Why?
|
| Heterozygote | 1 | 1998 | 110 | 0.010 |
Why?
|
| Autoradiography | 2 | 1993 | 37 | 0.010 |
Why?
|
| Phenethylamines | 1 | 1977 | 1 | 0.010 |
Why?
|
| Cricetinae | 1 | 1978 | 241 | 0.010 |
Why?
|
| Ganglia, Autonomic | 1 | 1977 | 4 | 0.010 |
Why?
|
| Chick Embryo | 1 | 1977 | 79 | 0.010 |
Why?
|
| Substantia Nigra | 1 | 1977 | 52 | 0.010 |
Why?
|
| NAD | 2 | 1979 | 45 | 0.010 |
Why?
|
| Hydroxydopamines | 2 | 1987 | 4 | 0.010 |
Why?
|
| Oxidopamine | 2 | 1987 | 23 | 0.010 |
Why?
|
| Phenotype | 1 | 1998 | 780 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 1998 | 1035 | 0.010 |
Why?
|
| Atrophy | 1 | 1995 | 51 | 0.010 |
Why?
|
| Mutation | 1 | 1999 | 1177 | 0.010 |
Why?
|
| Nerve Degeneration | 1 | 1994 | 111 | 0.010 |
Why?
|
| Mental Disorders | 1 | 1998 | 392 | 0.010 |
Why?
|
| Stereotaxic Techniques | 1 | 1992 | 20 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 1989 | 2853 | 0.010 |
Why?
|
| Receptors, Serotonin | 1 | 1992 | 23 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1995 | 972 | 0.010 |
Why?
|
| Glyceraldehyde | 1 | 1971 | 3 | 0.010 |
Why?
|
| Malates | 1 | 1971 | 3 | 0.010 |
Why?
|
| Fluorometry | 1 | 1971 | 17 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1971 | 47 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1992 | 283 | 0.010 |
Why?
|
| Transferases | 1 | 1971 | 14 | 0.010 |
Why?
|
| Rabbits | 1 | 1971 | 278 | 0.010 |
Why?
|
| Spermatogenesis | 1 | 1991 | 161 | 0.010 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 1989 | 2 | 0.000 |
Why?
|
| Oxidation-Reduction | 1 | 1971 | 457 | 0.000 |
Why?
|
| Synaptosomes | 1 | 1988 | 23 | 0.000 |
Why?
|
| Adult | 1 | 2004 | 13872 | 0.000 |
Why?
|
| Prazosin | 1 | 1987 | 9 | 0.000 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 1987 | 12 | 0.000 |
Why?
|
| Blood Vessels | 1 | 1987 | 36 | 0.000 |
Why?
|
| Guinea Pigs | 1 | 1987 | 143 | 0.000 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1987 | 196 | 0.000 |
Why?
|
| Calcifediol | 1 | 1986 | 17 | 0.000 |
Why?
|
| Vaginal Diseases | 1 | 1986 | 9 | 0.000 |
Why?
|
| Hemorrhage | 1 | 1986 | 55 | 0.000 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1987 | 458 | 0.000 |
Why?
|
| Blood-Brain Barrier | 1 | 1987 | 173 | 0.000 |
Why?
|
| Precancerous Conditions | 1 | 1986 | 83 | 0.000 |
Why?
|
| Uterine Neoplasms | 1 | 1986 | 53 | 0.000 |
Why?
|
| Hypophysectomy | 1 | 1984 | 4 | 0.000 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 1986 | 126 | 0.000 |
Why?
|
| Dexamethasone | 1 | 1984 | 55 | 0.000 |
Why?
|
| Calcium | 1 | 1986 | 491 | 0.000 |
Why?
|
| Infusions, Parenteral | 1 | 1982 | 13 | 0.000 |
Why?
|
| alpha-Fetoproteins | 1 | 1982 | 32 | 0.000 |
Why?
|
| Quinuclidinyl Benzilate | 1 | 1980 | 2 | 0.000 |
Why?
|
| Receptors, Androgen | 1 | 1982 | 144 | 0.000 |
Why?
|
| Pituitary Gland, Anterior | 1 | 1977 | 12 | 0.000 |
Why?
|
| Species Specificity | 1 | 1977 | 286 | 0.000 |
Why?
|
| Organ Specificity | 1 | 1975 | 141 | 0.000 |
Why?
|